Every Form 4 that Delek Us Hldgs Inc (DK) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow DK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DK filings page.
Delek US Holdings, Inc. (DK) reported that executive vice president for special projects Reuven Spiegel sold a total of 7,500 shares of common stock on September 1, 2026 in open-market or private transactions, at prices around the low $73 range per share. No Rule 10b5-1 trading plan is reported for these sales.
Delek US Holdings, Inc. (DK) director Gary M. Sullivan Jr. reported selling 27,688 shares of common stock on August 24, 2026. The sale was in the open market at a weighted average price of about $69.01 per share, with individual trade prices ranging from $69.00 to $69.15. After these transactions, he directly holds 32,004 shares of Delek US common stock.
Delek US Holdings, Inc. (DK) director Richard J. Marcogliese reported a sale of 2,000 shares of common stock on 2026-08-21 at $71.05 per share. The shares were held indirectly through the Marcogliese Family Revocable Trust, where he and his spouse are co-trustees and beneficiaries. After this transaction, the trust held 12,880 indirect shares, and he also reported 40,883 shares held directly.
Delek US Holdings, Inc. (DK) director William J. Finnerty reported a sale of 1,457 shares of Common Stock on 2026-08-21 in an open market or private transaction at $64.70 per share. After this transaction, he directly holds 33,348 shares of Delek US Holdings, Inc. Common Stock.
Delek US Holdings, Inc. (DK) reported that executive vice president, Special Projects, Reuven Spiegel filed a Form 4 for one open-market sale of 10,000 shares of common stock on August 18, 2026 at $68.21 per share. After this transaction, he directly holds 36,435 shares. The sale was made pursuant to a Rule 10b5-1 trading plan, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Delek US Holdings, Inc. (DK) reported that Mark Wayne Hobbs, EVP of Delek Logistics, sold a total of 20,000 shares of common stock on 2026-08-17 in open-market transactions under a Rule 10b5-1 trading plan. The sales occurred in two tranches at weighted average prices of $64.364 and $65.284 per share, with each price representing multiple trades within specified ranges. The filing notes that these transactions complete this 10b5-1 plan.
Delek US Holdings, Inc. (DK) reported that President & CEO Avigal Soreq sold a total of 80,000 shares of common stock on 2026-08-17 in four open‑market transactions under a Rule 10b5-1 trading plan. The weighted average sale prices were $64.383 for 4,603 shares, $65.351 for 4,623 shares, $66.616 for 57,700 shares, and $67.202 for 13,074 shares, with each price representing a weighted average over multiple trades within the disclosed intraday price ranges. A footnote states these trades were made pursuant to a 10b5‑1 plan intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c) and that these transactions complete this plan.
Delek US Holdings, Inc. director Ezra Uzi Yemin, through Yemin Investments, LP, reported open-market sales of an aggregate 200,000 shares of common stock on 2026-08-13. The shares were sold in multiple trades at weighted average prices of $65.75, $66.64, $67.74 and $68.27 per share, each representing numerous transactions within disclosed price ranges, pursuant to a Rule 10b5-1 trading plan that has now been completed. Following these transactions, Yemin reports 213,717 shares of Delek US common stock held directly.
Delek US Holdings director William J. Finnerty reported an open-market sale of 5,000 shares of Common Stock at $51.50 per share on June 29, 2026. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
After this sale, Finnerty continues to hold 34,805 Delek US shares directly, indicating he retains a substantial equity stake while realizing some liquidity in a planned, systematic manner.
FINNERTY WILLIAM J reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings director William J. Finnerty received a stock grant of 3,436 shares of Common Stock on June 10, 2026, at a reported value of $48.01 per share. This compensation-related award increased his direct ownership to 39,805 shares. The filing reports no sales or derivative transactions.
Delek US Holdings director Vicky Sutil received 3,436 shares of common stock as an equity grant at $48.01 per share. This award was reported as an acquisition under transaction code A and increased her direct holdings to 32,804 shares, reflecting routine stock-based compensation rather than an open-market trade.
Delek US Holdings EVP and CFO Mark Wayne Hobbs reported a routine tax-withholding share disposition. On the vesting of equity awards, 823 shares of common stock were withheld at a reference price of $48.01 per share to cover tax obligations, as noted in the footnote.
After this non-market transaction, Hobbs directly owned 124,326 shares of Delek US Holdings common stock. This type of Form 4 event reflects standard equity-compensation administration rather than an open-market purchase or sale.
Delek US Holdings EVP Robert G. Wright reported a small tax-related share disposition. On the vesting of equity awards, 846 shares of Delek US Holdings common stock were withheld at a price of $48.01 per share to cover tax obligations. After this non-market transaction, he directly holds 46,278 shares.
Delek US Holdings President & CEO Avigal Soreq reported a routine tax-related share disposition. On the vesting of equity awards, 3,810 shares of common stock were withheld to cover taxes at a value of $48.01 per share. After this withholding, Soreq directly holds 311,486 shares of Delek US common stock, indicating the event is primarily an administrative step tied to compensation rather than an open-market trade.
Delek US Holdings EVP and General Counsel Denise Clark McWatters reported a tax-related share disposition tied to equity compensation. On this Form 4, 3,496 shares of common stock were withheld at $48.01 per share to cover taxes upon vesting of equity awards. After this withholding, she directly owns 70,700 shares of Delek US common stock, reflecting a routine compensation and tax-settlement event rather than an open-market trade.
Sullivan Gary M Jr. reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings director Gary M. Sullivan Jr. received an award of 3,436 shares of common stock on June 10, 2026 at a price of $48.01 per share. After this grant and an adjustment, he beneficially owns 59,692 shares directly.
A footnote explains that his beneficially owned shares were increased by 500 shares to correct an inadvertent administrative error, indicating a bookkeeping correction rather than an additional market transaction.
Schwartzstein Christine Benson reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings director Christine Benson Schwartzstein received a grant of 3,436 shares of common stock on June 10, 2026, valued at $48.01 per share. This was an equity award rather than an open-market purchase. After the grant, she directly owns 18,613 shares of Delek US common stock.
Delek US Holdings, Inc. director Ezra Uzi Yemin reported a compensation-related stock grant. He received 3,436 shares of common stock on June 10, 2026 at $48.01 per share, classified as a grant or award rather than an open-market purchase.
Following this grant, Yemin directly owns 213,717 common shares. He also has an indirect position of 447,795 common shares held through Yemin Investments, LP. The filing shows an acquisition of shares, not a sale or disposition.
Moreno Leonardo reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings director Leonardo Moreno received an award of 3,436 shares of Common Stock. The shares were valued at $48.01 per share on the transaction date. After this grant, Moreno directly holds a total of 26,434 Delek US Holdings common shares.
Tolson Laurie Z. reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings, Inc. director Laurie Z. Tolson received a grant of 3,436 shares of common stock on June 10, 2026. The grant is recorded at a reference price of $48.01 per share and brings her direct holdings to 21,662 shares. This is a compensation-related share award rather than an open-market purchase.
Zohar Shlomo reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings, Inc. director Zohar Shlomo received a grant of 3,436 shares of common stock, recorded at a price of $48.01 per share. This was a compensation-related award, not an open-market purchase. Following the grant, Shlomo directly holds 10,082 common shares.
Delek US Holdings director Richard J. Marcogliese received a grant of 3,436 shares of common stock. The award was recorded at $48.01 per share and is classified as a grant or other acquisition, not an open-market purchase. Following this compensation-related transaction, he directly holds 55,763 common shares.
Delek US Holdings EVP Reuven Spiegel reported a routine tax-withholding transaction related to equity compensation. On the vesting of equity awards, 1,937 shares of common stock were withheld to cover taxes at a value of $48.01 per share. After this non-market disposition, Spiegel directly holds 46,435 shares of Delek US common stock.
Delek US Holdings EVP Robert G. Wright reported a routine tax-related share disposition. On the vesting of equity awards, 1,024 shares of common stock were withheld to cover tax obligations at an indicated value of $46.55 per share. After this withholding, Wright directly holds 47,124 shares of Delek US common stock, and the filing shows no open-market purchases or sales.
Delek US Holdings director Vicky Sutil reported an open-market sale of the company’s common stock. On June 3, 2026, she sold 1,871 shares at a price of $48.00 per share.
After this transaction, Sutil directly owned 29,368 shares of Delek US Holdings common stock, as reported in the filing.
Delek US Holdings director Vicky Sutil reported two open-market sales of the company’s Common Stock. On May 29, 2026, Sutil sold 1,848 shares at $45.00 per share, followed by 3,061 shares at $46.00 per share on June 1, 2026. After these transactions, Sutil directly holds 31,239 shares of Delek US Holdings Common Stock.
Delek US Holdings director Vicky Sutil sold 1,849 shares of Common Stock in an open-market transaction. The shares were sold at an average price of $44.035 per share. After this sale, Sutil directly holds 36,148 shares of Delek US Holdings Common Stock.
Delek US Holdings executive Reuven Spiegel reported an open-market sale of company stock. On May 18, 2026, he sold 10,000 shares of Delek US Holdings common stock at $44.36 per share. After this transaction, he directly holds 48,372 shares of common stock.
The filing notes the sale was executed under a Rule 10b5-1 trading plan, which is a pre-arranged program intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Delek US Holdings director Laurie Z. Tolson reported an open-market sale of common stock. On May 18, 2026, Tolson sold 4,921 shares of Delek US Holdings, Inc. at a weighted average price of $46.30 per share.
The filing states that the sale prices ranged from $46.27 to $46.38 per share. After this transaction, Tolson directly owns 18,226 shares of Delek US Holdings common stock.
Delek US Holdings, Inc. executive vice president Robert G. Wright reported an open-market sale of Common Stock. On May 13, 2026, he sold 10,720 shares at an average price of $47.07 per share.
Following this transaction, Wright directly owns 48,148 shares of Delek US Holdings common stock. This filing reflects a personal portfolio move by a senior executive, showing that he continues to hold a substantial stake after the sale.
Delek US Holdings director Ezra Uzi Yemin reported an open-market sale of 34,026 shares of common stock on May 4, 2026, at a weighted average price of $47.29 per share. The shares were sold indirectly through Yemin Investments, LP pursuant to a pre-arranged Rule 10b5-1 trading plan. Following this transaction, Yemin holds 447,795 shares indirectly through Yemin Investments, LP and 210,281 shares directly.
Russell Amber reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings, Inc. Executive Vice President of Refining Amber Russell reported an equity compensation award. Russell received 42,798 shares of common stock on a grant basis, reflected at $0.00 per share, as part of a time-vesting restricted stock unit award.
The RSUs vest over three years, meaning the shares are earned gradually if continued service conditions are met. Following this grant, Russell’s reported direct ownership is 42,798 shares, and there are no derivative (option or similar) positions shown in this filing.
Delek US Holdings director Ezra Uzi Yemin reported pre-planned open-market sales of 105,968 shares of Common Stock under a Rule 10b5-1 trading plan. On April 29, 2026 and May 1, 2026, shares were sold at weighted average prices around $44.86–$47.03.
Part of the stock was held directly and part through Yemin Investments, LP. After these transactions, Yemin continues to hold 210,161 shares directly and 481,941 shares indirectly, according to the filing.
Delek US Holdings, Inc. director William J. Finnerty reported an open-market sale of 5,000 shares of Common Stock at $47.50 per share. The transaction was made pursuant to a Rule 10b5-1 trading plan. After this sale, he directly holds 36,369 shares.
Delek US Holdings director Zohar Shlomo sold 7,343 shares of common stock in an open-market transaction at $46.00 per share. The sale occurred on March 19, 2026 and was executed under a pre-arranged Rule 10b5-1 trading plan. After this transaction, Shlomo directly holds 6,646 Delek US shares.
Director Ezra Uzi Yemin reported open-market sales totaling 55,356 shares of Delek US Holdings, Inc. common stock on March 18, 2026. The trades were executed at weighted average prices of $43.73 and $44.20 per share, across price ranges from $43.07 to $44.48.
After these sales, Yemin holds 228,419 shares directly and 569,651 shares indirectly through Yemin Investments, LP. The transactions were made under a pre-arranged Rule 10b5-1 trading plan, which indicates the timing was scheduled in advance rather than opportunistic.
Delek US Holdings director William J. Finnerty sold 5,000 shares of Common Stock in an open-market transaction at $45.50 per share. After the sale, he directly holds 41,369 shares. The transaction was executed under a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Delek US Holdings EVP Denise Clark McWatters reported an open-market sale of 11,988 shares of common stock at $41.33 per share. After this transaction, she directly holds 74,196 shares of Delek US Holdings common stock, indicating she retains a substantial ongoing equity stake in the company.
Delek US Holdings EVP Robert G. Wright reported routine equity compensation activity. On March 10, 2026, he acquired 12,934 shares of common stock at no cost upon vesting of performance-based restricted stock units and received a separate grant of 3,075 time-vesting restricted stock units that vest over three years.
On the same date, 9,562 shares were withheld at a price of $40.64 per share to cover tax obligations related to these equity awards, rather than being sold on the open market. After these transactions, Wright directly owned 58,868 shares of Delek US Holdings common stock.
Spiegel Reuven reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings EVP, Special Projects Reuven Spiegel received a grant of 9,842 shares of common stock as a time-vesting restricted stock unit award that vests over three years. After this compensation-related grant, his direct holdings increased to 58,372 common shares.
Delek US Holdings director Zohar Shlomo sold 5,000 shares of common stock in an open-market transaction at a price of $41.465 per share.
After this sale, Shlomo directly holds 13,989 shares of Delek US Holdings common stock, according to the latest ownership figures reported.
Delek US Holdings President & CEO Avigal Soreq reported multiple equity award transactions in common stock. On March 9 and 10, 2026, he acquired 95,249 shares through grants and vesting of restricted stock units, including performance-based awards and a new grant that vests over three years.
Across the same dates, 31,631 shares were disposed of at prices of $40.13 and $40.64 per share to cover tax obligations upon vesting of equity awards. After these transactions, Soreq directly holds 315,296 shares of Delek US Holdings common stock, indicating these are routine compensation-related grants and tax withholdings rather than open-market trades.
Delek US Holdings EVP and General Counsel Denise Clark McWatters reported routine equity compensation activity in company stock. On March 9 and 10, she received grants totaling 13,513 shares of common stock at no cost upon vesting of performance-based restricted stock units. In connection with these vestings, 11,606 shares were automatically withheld to cover tax obligations at prices of $40.13 and $40.64 per share, rather than sold on the open market. After these transactions, she directly holds 86,184 shares of Delek US Holdings common stock.
Delek US Holdings EVP and CFO Mark Wayne Hobbs reported stock-based compensation activity involving the company’s common stock. On March 9–10, he acquired multiple share awards at no cash cost to him, including grants tied to the vesting of performance-based and time-vesting restricted stock units.
The filing also shows 6,388 shares were disposed of through share withholding to cover tax obligations upon vesting, rather than through open-market sales. After these transactions, Hobbs directly holds 125,149 shares of Delek US Holdings common stock.
Delek US Holdings EVP Israel Joseph reported equity compensation-related transactions in company common stock. On March 6, he received 4,301 shares as a grant or award, tied to the vesting of performance-based restricted stock units. That same day, 1,693 shares were withheld at $42.29 per share to cover tax obligations on the vesting.
On March 9, an additional 353 shares were withheld at $40.13 per share for tax purposes. After these transactions, Joseph directly held 57,878 shares of Delek US common stock. The dispositions reflect tax-withholding mechanics rather than open-market sales.
Delek US Holdings director Ezra Uzi Yemin reported open-market sales of Delek common stock. On March 4, 2026, he sold 18,139 directly owned shares at a weighted average price of $43.17 per share, leaving 240,281 shares held directly.
On the same date, 66,511 shares were sold indirectly through Yemin Investments, LP at the same weighted average price, with 613,145 shares remaining held indirectly. The filing notes these transactions were made under a Rule 10b5-1 trading plan adopted on December 3, 2025, using multiple trades between $43.00 and $43.57 per share.
Delek US Holdings director Zohar Shlomo reported open‑market sales of company common stock under a pre‑arranged trading plan. On March 4–5, 2026, he sold a total of 29,372 shares of Delek US Holdings common stock in several transactions at prices between $43.00 and $45.50 per share. Following these sales, he directly owned 18,989 shares of the company’s common stock. The filing notes that these transactions were made pursuant to a Rule 10b5‑1 trading plan adopted on November 13, 2025, intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c).
Delek US Holdings EVP Israel Joseph reported an open-market sale of 38,000 shares of common stock on March 4, 2026 at a weighted average price of $40.65 per share. After this transaction, he directly owned 55,623 shares of Delek US common stock.
The reported price reflects multiple trades with individual sale prices ranging from $40.10 to $40.93 per share, aggregated into a single weighted average figure for disclosure.
Delek US Holdings, Inc. executive vice president of special projects Reuven Spiegel reported an open-market sale of common stock. On March 4, 2026, he sold 20,000 shares at a weighted average price of $42.84 per share, in multiple trades between $42.80 and $42.98. After this sale, he directly owned 48,530 shares of Delek US common stock.
Delek US Holdings, Inc. director William J. Finnerty sold 5,392 shares of common stock in an open‑market transaction at $42.75 per share on March 4, 2026, leaving him with 46,369 directly owned shares after the sale.